Prevalence of post-thrombotic syndrome following asymptomatic thrombosis in survivors of acute lymphoblastic leukemia

J Thromb Haemost. 2008 Apr;6(4):589-94. doi: 10.1111/j.1538-7836.2008.02901.x. Epub 2008 Jan 11.

Abstract

Background: Deep vein thrombosis (DVT) is a complication of treatment of acute lymphoblastic leukemia (ALL) in children but little is known about the long-term outcomes of these DVT.

Objective: To determine the incidence of post-thrombotic syndrome (PTS) in (i) children with ALL diagnosed with asymptomatic DVT using radiographic testing and (ii) an unselected group of ALL survivors.

Methods: Cross-sectional study in two populations. Group I comprised children in the Prophylactic Antithrombin Replacement in Kids with ALL treated with L-Asparaginase (PARKAA) study diagnosed with DVT by radiographic tests. Group II consisted of non-selected childhood ALL survivors <21 years. PTS was assessed using a standardized scoring sheet.

Results: Group I: 13 PARKAA patients (median age 12 years) were assessed, and 7 had PTS (54%; 95% CI, 25-81). All patients had collaterals, three also had increased arm circumference. Group II: 41 patients (median age 13 years) with a history of ALL were enrolled, and 10 had PTS (24%; 95% CI, 11-38). All patients had collaterals; five also had increased arm circumference.

Conclusion: There is a high incidence of PTS in survivors of childhood ALL with radiographically diagnosed asymptomatic DVT. A significant proportion of ALL survivors develop PTS, indicating previously undiagnosed DVT.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Antithrombin III Deficiency / chemically induced
  • Arm / blood supply
  • Arm / pathology
  • Asparaginase / administration & dosage
  • Asparaginase / adverse effects
  • Catheterization, Central Venous / adverse effects
  • Child
  • Child, Preschool
  • Clinical Trials, Phase II as Topic / statistics & numerical data
  • Collateral Circulation
  • Cross-Sectional Studies
  • Female
  • Follow-Up Studies
  • Humans
  • Incidence
  • Male
  • Multicenter Studies as Topic / statistics & numerical data
  • Postthrombotic Syndrome / epidemiology*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / blood
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Prevalence
  • Randomized Controlled Trials as Topic / statistics & numerical data
  • Survivors
  • Thrombophilia / chemically induced
  • Venous Thrombosis / complications*
  • Venous Thrombosis / epidemiology

Substances

  • Asparaginase